Catalyst Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $521K | Sell |
1,170
-191
| -14% | -$85K | 0.06% | 161 |
|
|
2025
Q1 | $660K | Buy |
1,361
+236
| +21% | +$114K | 0.12% | 115 |
|
|
2024
Q4 | $453K | Buy |
1,125
+39
| +4% | +$15.7K | 0.09% | 151 |
|
|
2024
Q3 | $505K | Buy |
1,086
+1
| +0.1% | +$465 | 0.1% | 138 |
|
|
2024
Q2 | $509K | Buy |
1,085
+67
| +7% | +$31.4K | 0.11% | 122 |
|
|
2024
Q1 | $400K | Buy |
1,018
+41
| +4% | +$16.1K | 0.1% | 133 |
|
|
2023
Q4 | $398K | Buy |
977
+36
| +4% | +$14.6K | 0.11% | 122 |
|
|
2023
Q3 | $327K | Buy |
941
+71
| +8% | +$24.7K | 0.11% | 146 |
|
|
2023
Q2 | $306K | Buy |
870
+121
| +16% | +$42.6K | 0.11% | 138 |
|
|
2023
Q1 | $236K | Buy |
+749
| New | +$236K | 0.1% | 156 |
|